Translating local innovation into statewide policy: Lessons from a medications for addiction treatment (MAT) prior authorization pilot in Camden, New Jersey

Author
Natasha Dravid and Alex Staropoli
Date
August 19, 2019
August 19, 2019
Translating local innovation into statewide policy: Lessons from a medications for addiction treatment (MAT) prior authorization pilot in Camden, New Jersey
In this brief, we outline our prior authorization pilot program and our work with partners to translate the pilot into successful statewide policy.
Natasha Dravid and Alex Staropoli
August 19, 2019
Camden residents identify barriers to health in their neighborhoods
Members of organizations that have participated in our Faith in Prevention program conducted a health assessment of their Camden neighborhoods.
Whitney Buchmann
Camden Coalition staff and Community Advisory Committee members participate at the Housing and Community Development Network of New Jersey’s Annual Legislative Day at New Jersey State House
July 18, 2019
Camden Coalition joins the call to fully fund the Affordable Housing Trust Fund
To help secure FY2020 funding for the Affordable Housing Trust Fund, CAC members took part in HCDNNJ's Annual Legislative Day at the NJ State House.
Whitney Buchmann
July 16, 2019
From siloed systems to ecosystem: The evolution of the Camden Coalition’s complex care model
In this four-part series, we describe the phases of our care model as we addressed challenges and tested new solutions.
Kathleen Noonan and Kelly Craig
July 15, 2019
Graduates of Interfaith Homeless Outreach Council program reflect on their fresh start
Now in its 28th year, the Interfaith Homeless Outreach Council — or IHOC — has transformed countless lives.
Bill Nice
Camden Coalition care team member helps patient fill medication box.
July 11, 2019
Bringing it home: The shift in where healthcare is delivered
In this blog post for JAMA Forum, Lauran Hardin and Diana Mason write about two new opportunities to incentivize innovative complex care models.
Lauran Hardin and Diana Mason

Between 2016 and 2017, New Jersey had the second highest increase in overdose deaths in the country. Improving access to medications for addiction treatment (MAT) is a critical tool in preventing these avoidable deaths. Having identified prior authorization as a barrier to accessing buprenorphine — one form of MAT — the Camden Coalition worked with local stakeholders to implement a pilot program that eliminated prior authorization for this life-saving medication in certain circumstances. The successful results of the pilot, along with collective advocacy at the state level, led to the removal of this administrative barrier for Medicaid beneficiaries across the state of New Jersey earlier this year. 

This Camden Coalition brief outlines the nuts and bolts of the pilot program and our work alongside partners at the local and state levels to translate the pilot into successful statewide policy.

Read the brief

Stay Informed

Join our mailing list to get the latest updates sent right to your inbox from the Camden Coalition.

Sign Up